2021-07-05
Laekna Therapeutics and Innovent enter a partnership agreement to co-develop combination therapy of afuresertib and sintilimab in clinical studies in China
Laekna Therapeutics and Innovent enter a partnership agreement to co-develop combination therapy of afuresertib and sintilimab in clinical studies in China
More
More